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Abstract
Mucosal-associated invariant T (MAIT) cells can recognize and respond to some bacterially
infected cells. Several in vitro and in vivo models of Mycobacterium tuberculosis (Mtb) infec-
tion suggest that MAIT cells can contribute to control of Mtb, but these studies are often
cross-sectional and use peripheral blood cells. Whether MAIT cells are recruited to Mtb-
affected granulomas and lymph nodes (LNs) during early Mtb infection and what purpose
they might serve there is less well understood. Furthermore, whether HIV/SIV infection
impairs MAIT cell frequency or function at the sites of Mtb replication has not been deter-
mined. Using Mauritian cynomolgus macaques (MCM), we phenotyped MAIT cells in the
peripheral blood and bronchoalveolar lavage (BAL) before and during infection with SIV-
mac239. To test the hypothesis that SIV co-infection impairs MAIT cell frequency and func-
tion within granulomas, SIV+ and -naïve MCM were infected with a low dose of Mtb Erdman,
and necropsied at 6 weeks post Mtb-challenge. MAIT cell frequency and function were
examined within the peripheral blood, BAL, and Mtb-affected lymph nodes (LN) and granu-
lomas. MAIT cells did not express markers indicative of T cell activation in response to Mtb
in vivo within granulomas in animals infected with Mtb alone. SIV and Mtb co-infection led to
increased expression of the activation/exhaustion markers PD-1 and TIGIT, and decreased
ability to secrete TNFα when compared to SIV-naïve MCM. Our study provides evidence
that SIV infection does not prohibit the recruitment of MAIT cells to sites of Mtb infection, but
does functionally impair those MAIT cells. Their impaired function could have impacts, either
direct or indirect, on the long-term containment of TB disease.
Author summary
MAIT cells are a population of immune cells that can directly detect and destroy some
bacterially infected cells. Evidence suggests that MAIT cells may play a role in control of
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Mycobacterium tuberculosis (Mtb) infection, but few studies have examined MAIT cell
activity within granulomas, which are the sites of Mtb replication. In addition, chronic
HIV infection has been shown to impair the frequency and function of MAIT cells in
humans, but these studies focus on peripheral blood and not the sites of Mtb infection.
Here, we used a macaque model of SIV and Mtb co-infection to determine whether SIV,
as a model for HIV, could dysregulate MAIT cells in tissues where Mtb replication is
occurring. SIV co-infection did not affect the absolute numbers of MAIT cells present
within granulomas but did impair the ability of the MAIT cells to respond to mycobacte-
ria both in vivo and in vitro. Overall, our study provides evidence that SIV infection alters
MAIT cells phenotypically, and impairs MAIT cell function. What effect this might have
on antimycobacterial immunity is an avenue for future exploration.
Introduction
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), and 10 million
new cases of TB occurred in 2018 alone [1]. Ninety percent of healthy humans are able to
immunologically control Mtb infection; however, TB remains a major global health concern.
One factor that can complicate the outcome of Mtb infection is co-infection with human
immunodeficiency virus (HIV). HIV+ individuals are 20 times more likely to develop active
TB disease and Mtb infection is the most common cause of death in HIV+ individuals [2, 3].
We do not understand fully the extent of immune responses that are dysregulated by HIV
and contribute to the weakened control of Mtb, particularly within granulomas and Mtb-
affected lymph nodes. [4]. Depletion of CD4 T cells is a hallmark of HIV infection. These cells
are also important for Mtb control, but the mechanism by which they control Mtb infection is
still not fully understood [5, 6]. Macaque studies have also shown that animals can maintain
control of latent Mtb infection, even when CD4 T cells are depleted [7, 8]. Further, HIV+ indi-
viduals treated with antiretroviral therapy with recovered peripheral CD4 T cell counts are still
at higher risk for TB, when compared to those who are HIV-naïve [9]. Together, these data
indicate that there must be non-CD4 T cell immune responses that are important for Mtb
control.
The contribution of mucosal associated invariant T (MAIT) cells to Mtb control is not well
understood. MAIT cells are a specialized population of T lymphocytic cells that recognize ribo-
flavin metabolites produced by some intracellular bacteria and presented by MR1 molecules
[10–13]. In humans and macaques, MAIT cells are highly abundant in the lungs and bronch-
oalveolar lavage (BAL) fluid, and express activation markers, such as CD69, in the blood fol-
lowing Mtb infection [14, 15]. In humans, MAIT cell frequencies are reduced in the blood
during active TB [13, 16–18]. Several in vitro studies have demonstrated the ability of MAIT
cells to respond to mycobacterial antigens [11, 14, 19, 20]. Furthermore, MR1 deficient mice
develop exacerbated TB [13, 21]. However, a recent study performed in Mtb-infected rhesus
macaques indicated that MAIT cells within the tissues or airways may not respond to Mtb
infection [22]. Indeed, little evidence exists to demonstrate that MAIT cells respond to Mtb
within the granulomas and affected LN.
The impact of HIV or SIV infection on MAIT cell frequency and function remains under
debate. Several cross-sectional human studies indicate that MAIT cells are depleted during
HIV infection, but the mechanism by which this occurs is not well understood. The depletion
has been suggested to occur from immune over-activation and subsequent apoptosis, as well
as possibly via downmodulation of surface receptors [17, 18, 23–26]. Similar to studies of HIV
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+ humans, the frequency of MAIT cells was also lower in one cross-sectional study of SIV+ rhe-
sus macaques, when compared to SIV-naïve controls [27]. These cross-sectional studies of
HIV/SIV+ individuals were challenged by recent longitudinal studies of HIV+ humans and
SIV+ pig-tailed macaques that found MAIT cells were not depleted during the first year of
infection [28, 29]. Notably, most of these studies only measured MAIT cells in the blood. A
recent report examining MAIT cells within the lungs of HIV+ and HIV-naïve patients with
active TB found that MAIT cell frequency was actually higher in the lungs of the HIV+ patients
compared to the HIV-naïve patients [30]. Overall, few studies to date have focused on how
HIV/SIV infection affects MAIT cell frequency and/or function within granulomas of Mtb-
infected individuals.
We previously established a macaque model of SIV and Mtb co-infection to study how pre-
existing SIV infection impairs the host immune response to Mtb. For these studies we used
Mauritian cynomolgus macaques (MCM), which have simplified major histocompatibility
complex (MHC) genetics [31]. Because of the simplified genetics, the adaptive immune
response is easier to characterize as many animals will have similar CD4 and CD8 T cell
responses to Mtb infection. We previously used MCM to generate tetramer reagents and char-
acterize Mtb-specific adaptive immune cell responses [32]. We found that SIV/Mtb co-infected
animals exhibited a more rapid increase in the number of granulomas between 4 and 8 weeks
post Mtb challenge, when compared to those infected with Mtb alone [33]. This observation
suggested that SIV infection impaired the ability of the co-infected MCM to contain Mtb infec-
tion some time between 4 and 8 weeks post-Mtb challenge.
In this study, we hypothesized that SIV infection would impair MAIT cell frequency and
function in Mtb-affected granulomas and LNs between 4 and 8 weeks after infection, when
compared to MAIT cells present in SIV-naïve animals. To test this hypothesis MCM were
infected with SIVmac239 for 6 months, followed by co-infection with a low dose of Mtb for 6
weeks. We included an SIV-naïve control group that was infected with only Mtb. There were
no striking clinical differences in TB progression between the two groups at necropsy just 6
weeks post Mtb. We also included another control group of animals that were infected with
SIVmac239 and then euthanized at 6 months after infection, at the time when they would oth-
erwise be challenged with Mtb. This control group was important to characterize MAIT cells
in the tissues of SIV+ animals, without being confounded by Mtb co-infection. Using these
groups of animals, we could determine whether SIV infection disrupted the frequency, pheno-
type, and/or function of MAIT cells in the blood and tissues, thus weakening their ability to
contain the initial Mtb infection.
Results
Characterization of MAIT cells in SIV-naïve MCM
We first defined the phenotype of MAIT cells in SIV-naïve MCMs. Frozen peripheral blood
mononuclear cells (PBMC) from 17 SIV-naïve MCM were stained with the Mamu-MR1-
5OP-RU tetramer. The MR1 tetramer-positive cells in the blood, henceforth referred to as
MAIT cells, were then further characterized. The gating schematic for MAIT cells is shown in
Fig 1A. MAIT cells comprised an average of 1.36% of the CD3+ T cells across the MCM tested.
All of the circulating MAIT cells were CD8+ in all animals examined, and no CD4+,
CD4-CD8-, or CD8+CD4+ MAIT cells were observed (Fig 1A). This was surprising given the
fact that in humans and mice, MAIT cells are more diverse in their CD4 and CD8 expression
[34–36]. The majority (>90%) of MAIT cells expressed TCRVα7.2 (Fig 1A; right panel) [35].
Given the predominant CD8 expression we observed, the rest of our analysis was performed
on CD8+MR1tet+ cells (Fig 1B). MAIT cells comprised a wide range (0.6%-17%) of the bulk
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Fig 1. Characterization of MAIT cells in SIV-naïve MCM. A, PBMC from 17 SIV naïve MCM were stained with the MR1-
5OP-RU tetramer along with antibodies to CD3, CD4, CD8, TCRVα7.2, CD28, CD95, PLZF1, RORγT, CCR6, CXCR3, CCR5,
CD127, and CCR7. Flow cytometry was performed as indicated in Methods. Shown is a representative gating schematic for CD4,
CD8, and TCRVα7.2 on CD3+MR1tet+ (black dots) and CD3+MR1tet- (gold dots) cells (left box). The right box shows the CD4,
CD8, and TCRVα7.2 expression, as well as the frequency of CD3+MR1tet+ cells for all 17 MCM. B, MR1tet+ cells were
characterized for their frequency as a percentage of the CD8+ cells, as well as their central memory (CD28+CD95+, red dots) or
effector memory (CD28-CD95+, blue dots) phenotypes. CD8+MR1tet+ cells were also plotted against the age of each animal to
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CD8+ T cell population, with an average of 4.6% of all CD8+ cells being MR1tet+ (Fig 1B). We
found that of those cells, 61% ±16% of circulating MAIT cells expressed a central memory
(CM) phenotype (CD28+CD95+) and that 28% ±17% expressed an effector memory (EM)
phenotype (CD28-CD95+; Fig 1B), indicating there was extensive animal to animal variability.
There were no correlations between the frequency of MAIT cells in the peripheral blood and
the age of the animal (R = 0.09, Fig 1B).
We also examined the expression of cell surface markers and transcription factors that are
associated with MAIT cells, such as CCR6 [37], PLZF1 [38], and RORγT [37, 39, 40]. A repre-
sentative example of the expression of these markers by CM and EM MAIT cells (CD8+-
MR1tet+ cells) compared to bulk CD8+ T cells (CD8+MR1tet- cells) is shown in Fig 1C. The
mean fluorescence intensities (MFI) for each of these markers across all MCM that were stud-
ied are shown in Fig 1D. Similar to previous studies [13, 41, 42], MAIT cells, but not conven-
tional CD8+ T cells, expressed TCRVα7.2 and PLZF1 (Fig 1C and 1D). Also consistent with
previous studies (reviewed in [43]), CM MAIT cells expressed high levels of RORγT and
CCR6, whereas the expression of these two markers was lower for EM MAIT cells, as well as
both CM and EM bulk CD8+ T cells (Fig 1C and 1D).
We examined the expression of CXCR3 and CCR5, both of which are associated with the
trafficking of T cells to the lungs [44]. CM MAIT cells expressed higher levels of CXCR3 and
CCR5, when compared to EM MAIT cells (Fig 1C and 1D). We also measured expression of
the LN homing marker CCR7 and the IL-7 receptor CD127 on MAIT and CD8+ T cells. Simi-
lar to other studies [45], we found that both CCR7 and CD127 were more highly expressed on
CM MAIT and CD8+ T cells than on EM MAIT and CD8+ T cells (Fig 1C and 1D).
MAIT cell numbers are not reduced during 6 months of SIV infection
Several cross-sectional studies reported fewer MAIT cells in HIV+ or SIV+ individuals, when
compared to healthy controls [17, 18, 24, 25, 27]. In contrast, two recent longitudinal studies
showed no decline in MAIT cell frequencies in SIV+ or SHIV+ pigtailed macaques and HIV
+ humans during the first year of infection [28, 29]. Here, we infected 4 MCM intrarectally
with 3,000 TCID50 of SIVmac239 and followed them for 6 months to determine if MAIT cells
were depleted in the blood. (Fig 2A). Plasma SIV viremia is shown in Fig 2B.
The frequency and phenotype of peripheral MAIT cells were measured longitudinally in
these 4 SIV+ animals (Fig 3A). Due to fluctuations in MAIT cell frequencies prior to SIV infec-
tion (Fig 3B) and the small number of animals, there were no statistically significant trends in
total, CM, or EM MAIT cell frequencies in blood during the 6 months of SIV infection (Fig
3B), similar to what was observed in [29].
We then characterized the phenotypes of CM and EM MAIT cells during SIV infection
using markers for T cell activation, proliferation, and exhaustion (CD69, CD25, HLADR, ki67,
CD39, PD-1, TIGIT), trafficking (CCR6, CCR5, CCR7, CXCR3, CD127), and transcriptional
markers of differentiation (T-bet, Eomes, RORγT, Fox3P) (Table 1, Fig 3A). For CM MAIT
cells, we found transient increases in ki67, CD69, CD39, T-bet, and RORγT between days 14–
21 post SIV (Fig 3C, top panels). In contrast, EM MAIT cells had a statistically significant
increase in only ki67 (Fig 3D, bottom panels) between days 14–21. While the activation mark-
ers CD69 and CD39 also showed transient increases, these changes did not reach the level of
significance (Fig 3D). Overall, these data suggest that MAIT cells are transiently activated
determine the relationship between MAIT frequencies and age. N.S. = not significant. C and D, The indicated EM and CM MAIT
and conventional CD8 T cell populations were characterized for their expression of the indicated markers. Figure C shows a
representative sample; Figure D shows the overall mean expression of the indicated markers across the population.
https://doi.org/10.1371/journal.ppat.1008585.g001
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during acute SIV infection (days 14–21 post infection), but then returned to basal activation
levels. We did not assess if the activation of MAIT cells or their increased expression of ki67
was occurring in a TCRVα7.2-dependent or -independent manner, but it was assumed to be
the latter based on previous studies of MAIT cell activation during viral infections (reviewed
in [46]).
SIV infection does not impair circulating MAIT cell frequency or
phenotype during Mtb infection
The role of MAIT cells within granulomas of Mtb-infected individuals is not well established
and whether SIV co-infection alters the frequency and function of MAIT cells within Mtb-
affected tissues is unknown. Here, we used our SIV/Mtb co-infection model [33] to determine
whether SIV disrupts the response of MAIT cells to infection with Mtb. We bronchoscopically
infected 11 MCM with a low dose of Mtb Erdman strain. Eight other MCM were first infected
intrarectally with 3,000 TCID50 SIV for 6 months and then co-infected with the same dose and
route of Mtb as the Mtb-only group (Fig 4A). Blood was collected at the timepoints indicated
by the red droplets in the diagram (Fig 4A).
We examined the frequency of circulating MAIT cells within the two cohorts (Fig 4B, left
panel). Similar to the animals infected with SIV alone (Fig 3), chronic SIV infection did not
lead to differences in the absolute number of circulating MAIT cells by 6 months of SIV infec-
tion (Fig 4B, left panel; red dots). The absolute number of MAIT cells also remained
unchanged for both the SIV-naïve and SIV+ groups following infection with Mtb (Fig 4B, left
panel). Additionally, no changes were observed in the absolute numbers of CM or EM subpop-
ulations of MAIT cells (Fig 4B, middle and right panels).
Phenotypic changes in the expression of surface markers and transcription factors associ-
ated with T cell activation, proliferation, differentiation, and exhaustion were determined as
described in Fig 3A. While the expression of most phenotypic markers remained unchanged
for both cohorts, there were statistically significant increases in the frequency of circulating
MAIT cells expressing ki67 following Mtb infection in both SIV-naïve and SIV+ animals (Fig
Fig 2. SIVmac239 infection of MCM. A, Four MCM were infected intrarectally with 3000 TCID50 of SIVmac239.
Blood was collected at the times post-SIV infection depicted by the red droplets. B, Plasma viral loads were determined
as indicated in the Methods. The Log10 virus copy equivalents/mL (ceq/mL) were graphed for each time point. The
limit of detection was 1x102 ceq/mL, as indicated by the dotted line.
https://doi.org/10.1371/journal.ppat.1008585.g002
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4C, left top panels). There were no marked differences in ki67 expression by MAIT cells
between the two cohorts for any time point post-Mtb infection (Fig 4C, left bottom panel).
Interestingly, the frequency of circulating MAIT cells expressing the early activation marker
CD69 trended significantly higher following Mtb co-infection in SIV+ animals, but not in the
SIV-naïve cohort (Fig 4C, right top panels). The frequency of CD69+ MAIT cells at 6 weeks
post-Mtb infection was significantly higher in SIV+ MCM, compared to animals that were
SIV-naïve (Fig 4C, right bottom panel).
Fig 3. MAIT cells in blood express an activated phenotype during acute SIV infection, but do not change in
frequency longitudinally. A, Flow cytometry was performed on cryopreserved PBMC from the timepoints indicated
in Fig 2A. Shown is the gating schematic used to examine the expression of the indicated markers on the EM and CM
subpopulations within the CD8+MR1tet+ parent gate. B, Total CM and EM MAIT cell counts (top panels) were
determined for each animal for each timepoint post-SIV infection. The fold-change in cell counts (bottom panels) was
determined by dividing the total cell counts for each timepoint by the average of the total cell counts pre-SIV infection.
C and D. Flow cytometry was performed as described in (A) and the fold change in the percent of CM (C) or EM (D)
MAIT cells expressing the indicated markers relative to their pre-SIV expression levels were determined. For statistical
analysis, repeated measures non-parametric ANOVA tests with Tukey’s multiple test correction were used to
determine statistical significance. � p<0.05.
https://doi.org/10.1371/journal.ppat.1008585.g003
Table 1. Antibodies used in staining panels for flow cytometry.
Marker Clone(s) Fluorochrome(s) Purpose of Use Surface/Intracellular/intranuclear
CD45 D058-1283 BV786 Lineage Surface
CD3 SP34-2 AF700, BV650 T cell marker Surface
CD4 OKT4, L200 PE Cy7, BV510, BV711, BV786 T cell marker Surface
CD8 RPAT8, SK1 PacBlue, BV510, BV605, BV711, BV786 T cell marker Surface
CD206 19.2 PE Cy5 Macrophage exclusion Surface
TCRVα7.2 3C10 BV421, BV605 MAIT cell marker Surface
CCR5 J418F1 BV421 Chemokine/MAIT lung homing Surface
CCR6 11A9 PE CF594, PE Cy7 Chemokine/gut homing Surface
CD127 MB15-18C9 PE IL-7 receptor Surface
CXCR3 G025H7 PE Dazzle 594 Chemokine/MAIT lung homing Surface
CCR7 FAB197F FITC Chemokine/lymph homing Surface
CD28 CD28.2 APC, BV510 T cell memory Surface
CD95 DX2 PE Cy5 T cell memory Surface
T-Bet 4B10 BV605 Transcriptional marker Intranuclear
Eomes WD1928 PE Cy7 Transcriptional marker Intranuclear
RORγT AFKJS-9 PE Transcriptional marker Intranuclear
PLZF1 R17-809 PE CF594 Transcriptional marker Intranuclear
Fox3P 150D AF488, AF647 Transcriptional marker Intranuclear
HLADR G46-6 BV650 T cell activation Surface
CD39 eBioA1 (A1) FITC, PE Cy7 T cell activation Surface
CD25 BC96,
M-A251
PE, BV605 T cell activation Surface
CD69 TP1.55.3 ECD T cell activation Surface
ki67 B56 AF647 T cell proliferation Intracellular
TIGIT MBSA43 FITC, PerCP EFluor710 T cell activation/exhaustion Surface
PD1 EH12.2H7 BV605 T cell activation/exhaustion Surface
IFNγ 4S.B3 FITC, BV510 Cytokine Intracellular
TNFα Mab11 AF700, PerCP Cy5.5 Cytokine Intracellular
CD107a H4A3 APC, BV605 Degranulation Surface
LIVE/DEAD ---- Near IR Dead cell stain ----
https://doi.org/10.1371/journal.ppat.1008585.t001
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Characterization of MAIT cells in BAL during SIV and/or Mtb infection
BAL fluid can be collected longitudinally following Mtb infection in macaques to assess the
early immune response within the airways during SIV/SHIV and Mtb infection [22, 29, 47].
We collected longitudinal BAL samples during SIV infection and characterized the frequency
and phenotype of MAIT cells as indicated in Fig 5A. At 4 weeks after SIV infection, there was
an increase in the frequency of CD45+ lymphocytes within the airways, which remained ele-
vated for the rest of the study (Fig 5B, left panel). Concurrently, the percent of total airway
CD8+ cells that were MR1 tet+ decreased (Fig 5B, middle panel). This was likely related to an
influx of CD3+CD8+MR1 tet-negative cells (Fig 5B right panel), as previously reported for
Fig 4. MAIT cells in blood upregulate ki67 during Mtb infection, but do not increase in frequency during Mtb
infection of SIV-naïve or SIV+ MCM. A, Schematic of the study design to investigate the role of MAIT cells during
Mtb infection in SIV-naïve (blue, n = 11) or SIV+ (red, n = 8) MCM. Red droplets indicate blood collection
timepoints. B, PBMC from the indicated time points post-SIV and/or post-Mtb infection were stained for MAIT cells,
and flow cytometry was performed as described in Fig 3A. Total, CM, and EM MAITs for SIV-naïve MCM (blue dots)
or SIV+ MCM (red dots) were calculated. C, Flow cytometry was performed as described in Fig 3A to measure the
expression of the indicated phenotypic markers on MAIT cells. The expression of ki67 and CD69 on MAIT cells was
measured longitudinally for each cohort (top panels). The mean +/-SEM are shown for each timepoint, and Wilcoxon
Rank signed tests for matched pairs were performed to determine statistical significance comparing pre-infection
timepoints to post-infection timepoints; � p<0.05, �� p<0.005. Mann-Whitney tests were used to compare differences
between SIV-naïve (blue dots) and SIV+ (red dots) MCM for the same timepoints post-Mtb infection; � p<0.05. N.S. =
not significant.
https://doi.org/10.1371/journal.ppat.1008585.g004
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SIV infection [47–49], thus increasing the ratio of conventional CD8+ T cells to MAIT cells
(Fig 5B).
Fig 5. Longitudinal analysis of MAIT cells in BAL. A, BAL fluid from SIVmac239-infected MCM was collected at the
indicated time post-SIV infection. Flow cytometry was performed, and a representative image of the gating schematic
used to determine MAIT cell frequencies within BAL is shown. B, The percent of lymphocytes present within each
BAL sample for each indicated timepoint was determined (left panel). Within the CD3+ parent gate, the frequency of
MR1tet+ cells (middle panel) and the CD8:MAIT cell ratio (right panel) were determined for each timepoint. C, The
frequency of CD8+MR1tet+ cells expressing HLA-DR, TIGIT, ki67, CD39, and PD-1 was determined. The mean
+/-SEM are shown for each timepoint, and repeated measures non-parametric ANOVA tests with Tukey’s multiple
test correction were performed to determine statistical significance between timepoints; � p� 0.05. D, BAL was
collected at the indicated timepoints (blue droplets) pre- and post-SIV and/or Mtb infection for 8 SIV/Mtb coinfected
MCM (red) and 8 Mtb-infected MCM (blue). Flow cytometry was performed as described in (A) and the frequency of
CD3+MR1tet+ cells was determined for the indicated timepoints.
https://doi.org/10.1371/journal.ppat.1008585.g005
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Similar to the activation of circulating MAIT cells during SIV infection (Fig 3), we observed
significant increases in MAIT cells expressing HLA-DR and CD39 in the BAL, peaking
between 2–6 weeks after SIV infection (Fig 5C, left-most panels). There were no changes dur-
ing SIV infection in the frequency of MAIT cells expressing activation/exhaustion markers
such as TIGIT and PD-1, or the proliferation marker, ki67 (Fig 5C, middle and right panels).
We also compared the expression of HLA-DR, CD39, TIGIT, PD-1, and ki67 on MAIT cells
within circulating PBMC collected at the same timepoints as the BAL (S1 Fig). Similar studies
have been performed in HIV+ individuals to compare the phenotypes of conventional CD4
+ and CD8+ T cells in the BAL vs PBMC [50]. Regardless of the timepoint or infection status,
HLA-DR, CD39, TIGIT, and PD-1 were more highly expressed on MAIT cells in the BAL
compared to the PBMC (S1 Fig), consistent with some of the findings with conventional T
cells in HIV+ individuals [51]. The MAIT cells in the BAL expressed lower ki67 levels than
those in the PBMC, again consistent with the findings in HIV+ individuals [51].
We also collected BAL fluid from SIV+ and SIV-naïve animals after Mtb infection and per-
formed flow cytometry (Fig 5D). We found that Mtb infection did not affect the frequency of
MAIT cells in either the SIV+ or SIV-naïve cohorts (Fig 5D). Due to small numbers of MAIT
cells within the BAL of the animals within these cohorts, we were unable to confidently charac-
terize the expression of activation markers.
Characterization of MAIT cells in tissues
To assess whether a pre-existing SIV infection impairs MAIT cell frequency or function within
Mtb-affected tissues, LNs and granulomas were collected from SIV-naïve or SIV+ MCM 6
weeks after Mtb infection and flow cytometry was performed (Fig 6A). At this relatively early
time point post Mtb infection (or co-infection), the TB disease (e.g. pathology, bacterial load)
did not differ significantly between the two cohorts.
The frequency of MAIT cells within Mtb-affected tissues was quantified for each cohort
(Fig 6B and 6C). Phenotypic differences in the expression of PD-1, TIGIT, ki67, IFNγ, and
TNFα were measured on MAIT cells residing within LNs and Mtb-affected tissues and com-
pared across the relevant cohorts.
We found that within Mtb-affected LNs, there was an increase in both the frequency and
absolute numbers of MAIT cells in SIV/Mtb co-infected MCM compared to MCM infected
with Mtb alone (Fig 6B). This increase in MAIT cell frequency appeared to be related to SIV
infection, as MAIT cells were also at a higher frequency in the peripheral LN of animals
infected with SIV alone when compared to the SIV-naïve, Mtb infected group (Fig 6B). We
found a weak negative correlation between MAIT cell frequency and bacterial burden in the
SIV/Mtb co-infected group (R = -0.46, p = 0.002; Fig 6B, right panels), but this correlation was
not significant for the SIV-naïve, Mtb infected group. MAIT cells in the LN of SIV+ animals,
regardless of whether the animals were co-infected with Mtb, expressed higher levels of PD-1
and TIGIT compared to SIV-naïve animals (Fig 6B, bottom left panels). While the frequency
of MAIT cells producing IFNγ was not different between cohorts, we did observe a reduction
in the frequency of MAIT cells producing TNFα in SIV/Mtb co-infected MCM compared to
MCM infected with Mtb alone (Fig 6B, bottom right panel). Overall, we conclude that SIV
infection leads to an increase in the frequency of activated MAIT cells in LNs.
Similar comparisons were made for the cells isolated from granulomas excised from SIV
+ and SIV-naïve animals following Mtb infection. The percentage of MAIT cells within the
granulomas was lower in the SIV+ cohort, compared to the SIV-naïve cohort (Fig 6C, top left
panel). However, absolute MAIT cell counts remained similar between both cohorts (Fig 6C,
top middle panel). This suggests that an influx of non-MAIT CD8+ T cells into granulomas
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Fig 6. Analysis of MAIT cell frequency in Mtb-infected tissues. A, Mtb-infected tissues were collected from SIV-naïve and
SIV+ MCM 6 weeks after Mtb infection. Tissues were processed according to Methods and cell homogenates were used for
flow cytometric analysis. Shown is the gating schematic used to examine the expression of the indicated markers on the CD8
+MR1tet+ cells. B, Homogenates collected from thoracic (circles) and extrathoracic (squares) LNs present in MCM infected
with Mtb (blue), SIV/Mtb (red), or SIV alone (black) were analyzed as indicated in (A) for the frequency of CD8+MR1tet
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(Fig 6C, top right panel) decreased the frequency of MAIT cells in those lesions. While there
was a weak negative correlation between absolute MAIT cell counts and bacterial burden in
granulomas from the SIV-naïve cohort (Fig 6C, middle left graph), there was no such correla-
tion in the SIV+ cohort (Fig 6C, middle right graph). In contrast to the LN, there were no dif-
ferences in the frequencies of MAIT cells expressing PD-1, TIGIT, ki67, or IFNγ (Fig 6C) in
the granulomas of SIV+ animals compared to those that were SIV-naïve. Notably, there was a
significant decrease in the frequency of MAIT cells producing TNFα in the SIV+ cohort com-
pared to the SIV-naïve cohort (Fig 6C, bottom right panel). Overall, the frequency of MAIT
cells did not appear to correlate with bacterial burden from both SIV-naïve and SIV+ animals.
However, at the sites of Mtb infection, there was a decrease in TNFα production by MAIT
cells in SIV+ MCM compared to those that were SIV-naive.
Ex vivo assessment of MAIT cell function throughout the course of SIV
infection
MAIT cell function can be assessed ex vivo by using paraformaldehyde-fixed bacteria as a stim-
ulus [52]. We stimulated MAIT cells with both paraformaldehyde fixed E. coli or M. smegmatis
as the MR1 molecule presents a different repertoire of ligands derived from each bacterial spe-
cies [53]. PBMC from SIV-naïve MCM were incubated with 10 CFU/cell of fixed E. coli or M.
smegmatis and flow cytometry was used to measure cytokine production and degranulation of
MAIT cells (Fig 7A). Examples of the gating schematic used for flow cytometry and produc-
tion of TNFα, IFNγ, and CD107a by MAIT cells can be found in S2 Fig. Among these samples,
incubation of PBMC with E. coli induced a greater production of TNFα and IFNγ, as well as
increased surface expression of the degranulation marker CD107a on MAIT cells (Fig 7A)
when compared to stimulation with M. smegmatis.
We wanted to determine whether the weaker stimulation of MAIT cells by ligands from M.
smegmatis, compared to E. coli, ligands was related to differential uptake of the bacteria by
antigen presenting cells. We labeled equal amounts of M. smegmatis and E. coli with a
pHRODO green dye which increases in fluorescence intensity when labeled bacteria are taken
up by antigen presenting cells, and has been used previously to measure the uptake of fixed E.
coli by antigen presenting cells for MAIT cell functional assays [52]. Increasing numbers of
labeled bacteria were delivered to SIV-naïve PBMC and the fluorescence intensity was mea-
sured after 3 hours. For each dose of labeled bacteria tested, there were no significant differ-
ences in the ability of PBMC to uptake M. smegmatis compared to E. coli (Fig 7A, right panel).
+ cells. Open circles/squares indicate samples from animals infected with Mtb that were sterile (Mtb culture negative). The
mean +/-SEM are shown for each group, and Kruskall-Wallis tests with Dunn’s adjusted p values were performed to calculate
statistical significance; ��� p<0.0001; � p<0.05. Top right two panels: Pearson correlation coefficients were calculated to
determine the relationship between the log-transformed values of the absolute MAIT cell counts and the log-transformed total
CFU for each sample. Shown are the correlations for samples collected from SIV-naïve (blue) and SIV+ (red). Bottom panels:
the expression of the indicated markers was determined for CD8+MR1tet+ cells. Prior to statistical analysis, the mean
expression of the indicated markers per animal were graphed and determined to eliminate animal bias. The mean +/-SEM are
shown for each group, with Kruskall-Wallis tests with Dunn’s adjusted p values were performed as indicated above for
statistical significance; �� p<0.001, � p<0.01. C, Top panels: CD8+MR1tet+ frequencies (left), and absolute cell counts
(middle) for granulomas of Mtb-infected MCM (blue) and SIV/Mtb-infected MCM (red) were determined as in B. Top right;
absolute CD8+ T cell (CD8+MR1tet-; grey bars) and MAIT cell (CD8+MR1tet+, black bars) counts within granulomas were
determined as described in (B). Middle panels: Pearson correlation coefficients were determined for the relationship between
total MAIT cell counts and total CFU as indicated in (C). Bottom panels: MAIT cells (CD8+tet+ cells) within granulomas
were characterized for their expression of the indicated markers as described in (B). Prior to statistical analysis, the mean
expression of the indicated markers per animal were graphed and determined to eliminate animal bias. The mean +/-SEM are
shown for each group, and Mann-Whitney statistical tests were performed; ���� p<0.00005.
https://doi.org/10.1371/journal.ppat.1008585.g006
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To determine if SIV infection alters MAIT cell function over time, PBMC were incubated
with 10 CFU/cell of fixed E. coli or M. smegmatis (Fig 7B). We observed robust cytokine and
CD107a production when cells were stimulated with E. coli, but weaker responses when M.
smegmatis was used (Fig 7B). No significant differences were observed in the production of
Fig 7. Longitudinal SIV infection does not impair ex vivo MAIT cell function. A, Functional assays were performed
as described in Methods using PBMC from four SIV-naïve MCM. Cells were stimulated for 16 hours with either 10
CFU per cell of fixed E. coli (black bars) or M. smegmatis (green bars). The samples were stained as indicated in
Methods, and the expression of CD107a, IFNγ, and TNFα were measured on CD8+MR1tet+ cells from stimulated
samples compared to an unstimulated sample control. Right panel: Bacterial uptake into PBMC was measured by
labeling equal amounts of bacteria with phRODO green dye as indicated in Methods, then incubating increasing
microbial doses of the labeled bacteria with PBMC for 5 hours. B, Functional assays and flow cytometry were
performed as described in (A) using PBMC collected at the indicated timepoints post-SIV infection for four SIV-
infected MCM. To compare expression of the indicated cytokines longitudinally for each individual animal for a single
stimulus, repeated measures ANOVA tests with Tukey’s multiple test correction was performed. C, LNs and PBMC
samples collected at the time of necropsy for the four SIVmac239 infected MCM described in (B) were used, and
functional assays using fixed E. coli (EC) and M. smegmatis (MS), or no stimulation (NS) were performed as described
in (A) and (B). MAIT cells were gated during flow cytometric analysis into two separate populations: CD8+MR1tet
+PD-1+ (black bars) and CD8+MR1tet+PD-1- (gray bars). CD107a, IFNγ, or TNFα were measured as shown.
Statistical analysis was performed as described in (A).
https://doi.org/10.1371/journal.ppat.1008585.g007
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TNFα, IFNγ, or CD107a at any time point measured pre- or post-SIV infection for either E.
coli or M. smegmatis stimuli. Overall, these data suggest that SIV infection does not affect the
function of circulating MAIT cells over time.
Functional assays were performed using PBMC and LN samples collected at the time of
necropsy to determine if MAIT cell function was affected by the increased expression of PD-1
we observed during SIV infection. We found that in both PBMC and LN, cytokine production
was similar for PD-1+ and PD-1-negative MAIT cells after stimulation with either E. coli or M.
smegmatis (Fig 7C). Taken together, no defects in ex vivo MAIT cell activity were apparent
during SIV infection in response to either bacterial stimulus.
Reduced production of TNFα by MAIT cells after Mtb infection in SIV
+ MCM, compared to SIV-naïve MCM
To determine whether Mtb infection could enhance or inhibit the in vitro MAIT cell response
to bacterial stimuli, when compared to naïve animals, we performed in vitro functional assays
using PBMC from the SIV-naïve and SIV+ animals following Mtb infection (Fig 8). Although
stimulation with E. coli elicited more robust cytokine production when compared to stimula-
tion with M. smegmatis (Fig 8A), there were no differences in MAIT cell cytokine production
before and after Mtb infection. Likewise, for the SIV+ MCM, MAIT cell function did not differ
before and after SIV infection (Fig 8B). However, we found a lower frequency of MAIT cells
producing TNFα after Mtb co-infection in response to both the E. coli and M. smegmatis sti-
muli (Fig 8B, right panel). This is consistent with the reduced production of TNFα by MAIT
cells we observed directly ex vivo from LNs and granulomas from SIV/Mtb co-infected MCM
when compared to animals infected with Mtb alone (Fig 6). We analyzed cytokine production
within the same in vitro functional assays for the CD8+MR1tet- cells (conventional CD8 T
cells, S3A–S3C Fig). Fixed bacteria were able to stimulate the production of TNFα and IFNγ,
but not CD107a, in conventional CD8+ T cells (S3A and S3B Fig). There were no differences
longitudinally in cytokine production by conventional CD8+ T cells for the MCM infected
with Mtb alone (S3A Fig). However, there were impairments in both TNFα and IFNγ produc-
tion longitudinally in the SIV+ MCM, particularly by 6 weeks post Mtb infection (S3B Fig).
Further analysis of conventional CD4 and CD8 T cells is currently underway. While fixed bac-
teria are not the ideal stimulus for conventional CD8+ T cells, these observations further
strengthen the idea that SIV infection may indirectly impair the antibacterial immune
response by inhibiting cytokine production of other immune cell subsets.
Discussion
We previously observed that rapid early dissemination of granulomas was common among
SIV+ macaques between 4 and 8 weeks after Mtb infection, leading to their rapid TB progres-
sion and mortality [33]. Here, we wanted to test the hypothesis that SIV-dependent dysregula-
tion of MAIT cells could impair their frequency and function within Mtb-affected tissues. A
key aspect of our study was that we performed necropsies at 6 weeks after Mtb challenge.
Thus, we captured the phenotypes of the host immune response, right when Mtb control in
the SIV+ and SIV-naïve animals was beginning to diverge, and before they were influenced by
advanced TB disease. While there were no significant differences in measures of TB disease
(e.g. pathology, PET/CT imaging, bacterial load) between the SIV+ or SIV-naïve MCM at the
time the animals were necropsied, we would expect that the SIV+ animals would have rapidly
progressed to advanced TB disease [33]. Thus, defects observed in the immune responses in
the SIV+ animals, when compared to those that were SIV-naïve, should be considered as
potential mechanisms for increased TB progression in the SIV/HIV population.
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In this manuscript, we specifically characterized MAIT cells in SIV, Mtb, and SIV/Mtb co-
infected MCM to determine whether SIV infection dysregulated MAIT cell function. We phe-
notyped MAIT cells longitudinally during SIV infection, and also described the early MAIT
cell response to Mtb infection within Mtb-affected tissues (e.g. granulomas and LNs). Finally,
we show for the first time that SIV co-infection affects MAIT cell frequency and function
within granulomas. Separate studies evaluated the impact of SIV infection on the conventional
T cell response.
One key finding was that MAIT cells present in the granulomas and LNs of SIV/Mtb co-
infected animals produced less TNFα when measured directly ex vivo, compared to those pres-
ent in the granulomas of MCM infected with Mtb alone (Fig 6). The decreased TNFα produc-
tion by MAIT cells found in granulomas was supported by in vitro assays showing a trend
towards decreased TNFα production in MAIT cells isolated from SIV/Mtb co-infected animals
when stimulated with either E. coli or M. smegmatis (Fig 8). Similar defects were observed in
TNFα production from conventional CD8 T cells in the same in vitro assays (S3 Fig). Despite
this, the decreased production of TNFα by MAIT cells alone is very unlikely to be the only
Fig 8. SIV and Mtb co-infection results in functional impairment of TNFα production in MAIT cells in the blood.
A, Functional assays were performed as described in Fig 7A using PBMC from pre-Mtb (dark grey) and 6 weeks post-
Mtb (yellow) infection from seven Mtb-infected MCM (blue monkeys). Wilcoxon Rank sum statistical tests for
matched pairs were performed to compare the expression of the indicated cytokines or CD107a longitudinally for a
single stimulus. B, Functional assays were performed as decribed in (A) using PBMC from pre-SIV (dark grey), 20
weeks post-SIV (teal), and 6 weeks post-Mtb (yellow) infection from 6 SIV/Mtb coinfected MCM. Wilcoxon Rank sum
statistical tests for matched pairs were performed to compare the expression of the indicated cytokines and CD107a
longitudinally for a single stimulus. C, The functional assays performed in (A) and (B) using PBMC from six weeks
post-Mtb infection for SIV-naïve (blue dots) and SIV+ (red dots) MCM were plotted on the same graphs to compare
the expression of CD107a (first panel), IFNγ (second panel), or TNFα (third panel) amongst the two cohorts. Mann-
Whitney tests were performed to determine statistical significance.
https://doi.org/10.1371/journal.ppat.1008585.g008
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determinant for containment of Mtb infection. However, others have shown that anti-TNF
therapy or blocking TNFα production can lead to exacerbation of primary TB or reactivation
of latent Mtb infection in several animal models as well as Mtb-infected individuals [54–58].
Defective TNFα production has also been observed when alveolar macrophages were infected
with HIV in vitro [59]. Furthermore, a recent study has shown that MAIT cells were defective
in the production of TNFα during SHIV infection [60]. Overall, the mechanism by which SIV/
HIV impairs TNFα production has not yet been fully determined, but our data suggests that
SIV/HIV infection may dysregulate the ability of MAIT cells (Fig 8) as well as conventional
CD8 T cells (S3 Fig) to produce TNFα in response to mycobacteria. What role this may play in
Mtb containment has yet to be tested.
We were surprised to find that SIV infection did not dysregulate the activation and prolifer-
ative capacity of MAIT cells in the granulomas (Fig 6C). Overall, MAIT cells failed to robustly
respond to Mtb infection within the tissues (Fig 6), similar to a study performed in SIV-naïve
rhesus macaques that also showed that MAIT cells present in granulomas failed to produce
markers associated with proliferation [22]. One possible explanation for the in vivo (Fig 6)
findings reported here and by others [22] is that Mtb produces metabolites distinct from those
produced by E. coli or M. smegmatis, and thus our in vitro assays missed the MAIT cells that
specifically respond to Mtb. This is plausible, as different bacteria can produce distinct ligands
for presentation by MR1 [53]. Furthermore, there are MAIT cells with distinct TCR sequences
that can distinguish between ligands produced by M. smegmatis and Mtb [61]. Therefore,
future studies using in vitro assays to characterize MAIT cells in Mtb-affected tissue may need
to include Mtb as stimulating agent.
While we did find that E.coli and M.smegmatis differentially stimulated MAIT cells in vitro,
there are caveats to these observations. It has been established that MAIT cells do not always
respond to mycobacterial antigens by MR1/TCRVα7.2-dependent mechanisms [62]. For
example, Mycobacterium bovis (BCG) can stimulate MAIT cells in vitro through
TCRVα7.2-independent mechanisms [63]. On the other hand, MAIT cell clones derived from
Mtb-infected patients have been observed to respond to Mtb in a manner dependent upon
TCRVα7.2 and MR1 interaction [11]. There is some evidence that MAIT cell lines derived
from human patients produce cytokines in response to M.smegmatis infected cells in an
MR1-dependent manner [64]. It has yet to be tested whether the stimulation of MAIT cells by
M.smegmatis is occurring in an MR1-dependent or -independent manner in our animal
model. Furthermore, the fact that frozen PBMC were used for our functional assays should be
noted, as it may affect the ability of antigen-presenting cells to effectively present metabolites
or secrete cytokines. We were unable to obtain sufficient PBMC for the animals within this
study to grow autologous monocytes as antigen presenting cells, but future studies could
include them where possible.
While it is unclear whether MAIT cells have a direct role in antimycobacterial immunity,
SIV co-infection clearly affects their ability to secrete certain cytokines, such as TNFα (Fig 8).
MAIT cells secrete several proinflammatory cytokines in response to bacterial infection [43].
Cytokine secretion by MAIT cells responding to an Mtb infection could then provide signals
to conventional T cells that either lead to their activation or trafficking to the lungs or other
sites of infection [65, 66]. Furthermore, MAIT cells have recently been shown to provide sig-
nals to B cells to help develop antibody responses to pathogens [67]. Whether the SIV depen-
dent dysregulation of MAIT cell cytokine production has an indirect effect on recruitment or
activation of other immune cells during Mtb infection has not been assessed and may be inter-
esting to pursue in future studies.
Another interesting observation was the phenotypic differences between MAIT cells within
the LN versus those within granulomas. Granuloma-resident MAIT cells were similar between
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the SIV-naïve and SIV+ cohorts, except for lower TNFα production in the latter group. In con-
trast, the MAIT cells within Mtb-affected LNs from SIV+ MCM displayed increased expres-
sion of PD-1 and TIGIT compared to SIV-naïve MCM (Fig 6). We hypothesize that the
activation of MAIT cells in LNs was driven by SIV infection because both the SIV-only and
SIV/Mtb co-infected MCM expressed higher levels of these markers (Fig 6B). While we did
not find evidence that PD-1 expression was associated with MAIT cell exhaustion (Fig 7C), it
is likely that ongoing SIV replication can lead to the activation of MAIT cells. This was also
observed in the blood, where we detected transient increases in the circulating MAIT cells
with a higher expression of ki67, CD69, CD39, RORγT, and T-bet, coincident with peak vire-
mia (Fig 2, Fig 3B and 3C). The increase in ki67 is consistent with increased MAIT cell prolif-
eration observed by others during acute SIV/HIV infection [28, 29]. This type of TCR-
independent activation of MAIT cells has been observed for other viral infections as well [23].
We hypothesize that during active SIV replication, other immune cells are producing cyto-
kines such as IL-12 and IL-18 that can activate MAIT cells [68–70]. Therefore, MAIT cell acti-
vation may be occurring indirectly though TCR-independent mechanisms, rather than
directly through bacterial infection, but this hypothesis remains to be tested.
We did not explore the possibility that SIV infection might affect the trafficking of MAIT
cells to the sites of Mtb infection via modulation of chemokine receptors. There was an
increase in the number of MAIT cells present in the lymph nodes of SIV/Mtb co-infected
MCM compared to the SIV-naïve cohort (Fig 6B, left panels). However, within the SIV/Mtb
co-infected cohort we did observe an inverse relationship between the numbers of MAIT cells
within Mtb-affected lymph nodes and the total CFU present in those lymph nodes (Fig 6B,
right panels). We do not currently have evidence to support the hypothesis that MAIT cells
had an enhanced mycobacterial killing capacity in the samples with low total CFU. However,
it is possible that Mtb and/or SIV infection may affect the trafficking of MAIT cells to the
lymph nodes. For example, there may be modulation of lymph node homing markers such as
CCR7. Dendritic cells have been shown to upregulate CCR7 during Mtb infection [71]. Alter-
natively, increased MAIT cell activation during SIV and/or Mtb infection might increase the
surface expression of gut homing markers, such as α4β7, as was shown during SIV infection
[29]. Neither the modulation of CCR7 nor α4β7 on MAIT cells were evaluated in this study,
but should be explored in future experiments in the SIV/Mtb co-infection model.
Overall, our study shows that SIV differentially dysregulates the phenotypes of MAIT cells,
albeit depending on their tissue location. SIV infection activates MAIT cells and can impair
their ability to produce TNFα in Mtb-affected tissues. This virus-dependent activation of
MAIT cells has also been observed in HIV infection [28], and the failure of MAIT cells to
respond in a robust way to Mtb has also been observed in the tissues of rhesus macaques [22].
In our study, we combine SIV with Mtb co-infection to show that that SIV can induce activa-
tion of MAIT cells in vivo, and can also impair their ability to produce TNFα upon co-infec-
tion with Mtb. This unique SIV/Mtb co-infection model provides the opportunity to dissect
out how co-infection with two pathogens elicits distinct immune responses that may not be
apparent when individuals are infected with only SIV or Mtb, and thus provide insights into
the immunological defects that render HIV+ individuals so susceptible to TB.
Materials and methods
Animal care/Ethics statement
Mauritian cynomolgus macaques (macaca fascicularis; MCM) were obtained from Bioculture,
Ltd. (Mauritius). MCM with at least one copy of the M1 MHC haplotype were chosen for this
study. The macaques (n = 4) infected with SIV alone were cared for by the staff at the
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Wisconsin National Primate Research Center (WNPRC) in accordance with the regulations,
guidelines, and recommendations outlined in the Animal Welfare Act, the Guide for the Care
and Use of Laboratory Animals, and the Weatherall Report. The University of Wisconsin-
Madison (UW-Madison), College of Letters and Science and Vice Chancellor for Research
and Graduate Education Centers Institutional Animal Care and Use Committee (IACUC)
approved the nonhuman primate research covered under IACUC protocol G005507. The Uni-
versity of Wisconsin-Madison Institutional Biosafety Committee approved this work under
protocol B00000205. All macaques were housed in standard stainless-steel primate enclosures
providing required floor space and fed using a nutritional plan based on recommendations
published by the National Research Council. Macaques had visual and auditory contact with
each other in the same room. Housing rooms were maintained at 65–75˚F, 30–70% humidity,
and on a 12:12 light-dark cycle (ON: 0600, OFF: 1800). Animals were fed twice daily a fixed
formula, extruded dry diet with adequate carbohydrate, energy, fat, fiber, mineral, protein,
and vitamin content (Harlan Teklad #2050, 20% protein Primate Diet, Madison, WI) supple-
mented with fruits, vegetables, and other edible objects (e.g., nuts, cereals, seed mixtures,
yogurt, peanut butter, popcorn, marshmallows, etc.) to provide variety to the diet and to
inspire species-specific behaviors such as foraging. To further promote psychological well-
being, animals were provided with food enrichment, structural enrichment, and/or manipu-
landa. Environmental enrichment objects were selected to minimize chances of pathogen
transmission from one animal to another and from animals to care staff. While on study, all
animals were evaluated by trained animal care staff at least twice daily for signs of pain, dis-
tress, and illness by observing appetite, stool quality, activity level, physical condition. Animals
exhibiting abnormal presentation for any of these clinical parameters were provided appropri-
ate care by attending veterinarians. Prior to all minor/brief experimental procedures,
macaques were sedated with an intramuscular dose of ketamine (10 mg kg-1) and monitored
regularly until fully recovered from sedation. Per WNPRC standard operating procedure
(SOP), all animals received environmental enhancement including constant visual, auditory,
and olfactory contact with conspecifics, the provision of feeding devices which inspire foraging
behavior, the provision and rotation of novel manipulanda (e.g., Kong toys, nylabones, etc.),
and enclosure furniture (i.e., perches, shelves). At the end of the study, euthanasia was per-
formed following WNPRC SOP as determined by the attending veterinarian and consistent
with the recommendations of the Panel on Euthanasia of the American Veterinary Medical
Association. Following sedation with ketamine (at least 15mg/kg body weight, IM), animals
were administered at least 50 mg/kg IV or intracardiac sodium pentobarbital, or equivalent, as
determined by a veterinarian. Death was defined by stoppage of the heart, as determined by a
qualified and experienced individual.
MCM at the University of Pittsburgh (U.Pitt., n = 19) were housed in a BSL2+ animal facil-
ity during SIV infection and then moved into a BSL3+ facility within the Regional Biocontain-
ment Laboratory for infection with Mtb. Animal protocols and procedures were approved by
the U.Pitt. Institutional Animal Care and Use Committee (IACUC) which adheres to guide-
lines established in the Animal Welfare Act and the Guide for the Care and Use of Laboratory
Animals, and the Weatherall report (8th Edition). The U.Pitt. IACUC reviewed and approved
the IACUC study protocols 18032418 and 15035401, under Assurance Number A3187-01.
The IACUC adheres to national guidelines established in the Animal Welfare Act (7 U.S.C.
Sections 2131–2159) and the Guide for the Care and Use of Laboratory Animals (8th Edition)
as mandated by the U.S. Public Health Service Policy. Macaques were housed at U.Pitt. in
rooms with autonomously controlled temperature, humidity, and lighting. Animals were pair-
housed in caging measuring 4.3 square feet per animal and spaced to allow visual and tactile
contact with neighboring conspecifics. The macaques were fed twice daily with biscuits
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formulated for nonhuman primates, supplemented at least 4 days/week with fresh fruits, vege-
tables or other foraging mix. Animals had access to water ad libitem. An enhanced enrichment
plan is designed and overseen by our nonhuman primate enrichment specialist. This plan has
three components. First, species-specific behaviors are encouraged. All animals have access to
toys and other manipulanda, some of which are filled with food treats (e.g. frozen fruit, peanut
butter, etc.). These are rotated on a regular basis. Puzzle feeders, foraging boards, and card-
board tubes containing small food items also are placed in the cage to stimulate foraging
behaviors. Adjustable mirrors accessible to the animals stimulate interaction between cages.
Second, routine interaction between humans and macaques are encouraged. These interac-
tions occur daily and consist mainly of small food objects offered as enrichment and adhere to
established safety protocols. Animal caretakers are encouraged to interact with the animals by
talking or with facial expressions while performing tasks in the housing area. Routine proce-
dures (e.g. feeding, cage cleaning, etc.) are done on a strict schedule to allow the animals to
acclimate to a routine daily schedule. Third, all macaques are provided with a variety of visual
and auditory stimulation. Housing areas contain either radios or TV/video equipment that
play cartoons or other formats designed for children for at least 3 hours each day. The videos
and radios are rotated between animal rooms so that the same enrichment is not played repeti-
tively for the same group of animals. All animals are checked at least twice daily to assess appe-
tite, attitude, activity level, hydration status, etc. Following SIV and/or Mtb infection, the
animals are monitored closely for evidence of disease (e.g., anorexia, lethargy, tachypnea, dys-
pnea, coughing). Physical exams, including weights, are performed on a regular basis. Animals
are sedated prior to all veterinary procedures (e.g. blood draws, etc.) using ketamine or other
approved drugs. Regular PET/CT imaging is conducted on our macaques following Mtb infec-
tion and has proved very useful for monitoring disease progression. Our veterinary technicians
monitor animals especially closely for any signs of pain or distress. If any are noted, appropri-
ate supportive care (e.g. dietary supplementation, rehydration) and medications (e.g. analge-
sics) are given. Any animal considered to have advanced disease or intractable pain or distress
from any cause is sedated with ketamine and then humanely euthanized using sodium pento-
barbital (65 mg/kg, IV). Death is confirmed by lack of both heartbeat and pupillary responses
by a trained veterinary professional.
SIV and Mtb infection of MCM
At UW-Madison, 4 MCMs were infected intrarectally with 3,000 TCID50 SIVmac239. Six
months after infection, animals were humanely euthanized as indicated in the section above.
For studies performed at U.Pitt., animals in the SIV/Mtb co-infection group (n = 8) were
infected intrarectally with 3,000 TCID50 SIVmac239. After 6 months, the animals were co-
infected with a low dose (3–12 CFU) of Mtb (Erdman strain) via bronchoscopic instillation, as
described previously [33]. Animals in the SIV-naïve control group (n = 11) were infected with
Mtb in an identical manner. TB progression was monitored by clinical testing and PT/CT
imaging [33]. Six weeks after Mtb infection, animals were humanely euthanized, and necrop-
sies were performed using PET/CT images to guide the excision of all granulomas. Random
samples from each lung lobe were also harvested, as well as peripheral (axillary and inguinal)
LNs, all thoracic LNs, mesenteric LNs, liver, and spleen [72].
Sample collection
For all cohorts, whole blood and plasma samples were collected longitudinally pre- and post-
SIV and/or Mtb infection, and PBMC and were isolated by Ficoll density gradient purification
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as previously described [33, 73]. BAL samples were also collected at the indicated time points
pre- and post-SIV and/or Mtb infection as previously described [33].
Tissue samples were collected at necropsy, as detailed above. For the SIV-only cohort,
peripheral and thoracic LN were collected, single cell suspensions were prepared, and samples
were stained for flow cytometry. For the SIV-naïve and SIV+ MCM infected with Mtb at U.
Pitt, the tissue samples listed above were homogenized using Medimachines (BD Biosciences)
and each homogenate was divided. One portion was plated on 7H11 agar to quantify the Mtb
colony forming units (CFU) as previously described [33, 72], and the other portion was used
for flow cytometry.
Plasma viral loads
Plasma viral loads were quantified as previously described [73–76]. Briefly, viral RNA was iso-
lated from plasma, reverse transcribed, and amplified with the SuperScript III Platinum one-
step quantitative RT-PCR system (Thermo Fisher Scientific). Samples were then run on a
LightCycler480 (Roche) and compared to an internal standard curve on each run.
Flow cytometry
To characterize MAIT cells from peripheral blood, BAL, LN, and granulomas, the rhesus
macaque (Mamu) MR1 tetramer loaded with either the 5-OP-RU active metabolite or the Ac-
6-FP control metabolite were used [77]. The MR1 tetramer technology was developed jointly
by Dr. James McCluskey, Dr. Jamie Rossjohn, and Dr. David Fairlie, and the material was dis-
tributed by the NIH Tetramer Core Facility as permitted to be distributed by the University of
Melbourne. For PBMC, staining was performed using cryopreserved cells collected longitudi-
nally from the current study, or cryopreserved cells from SIV-naïve MCM collected from pre-
vious, unrelated studies. For BAL and tissue samples, freshly isolated cell homogenates were
used for staining.
Approximately 1x106 cells (or all cells obtained from granulomas with <1x106 cells) were
stained with 0.25 ug of Mamu MR1 5-OP-RU or Ac-6-FP tetramer for one hour in the pres-
ence of 500 nM Dasatinib (Thermo Fisher Scientific; Cat No. NC0897653). When TCRVα7.2
co-staining was performed, the antibody was added 30 minutes after the addition of the MR1
tetramer. Cells were washed once with FACS buffer (10% Fetal Bovine Serum (FBS) in a 1X
PBS solution) supplemented with 500 nM Dasatinib, then surface antibody staining was per-
formed for 20 minutes in FACS buffer + 500 nM Dasatinib. A complete list of antibodies used
for surface staining is shown in Table 1. Samples were fixed in 1% paraformaldehyde for a
minimum of 20 minutes. For intracellular staining, cells were washed twice with FACS buffer
and staining with antibodies was performed in Medium B permeabilization buffer (Thermo
Fisher Scientific, Cat. No. GAS002S-100) for 20 minutes at room temperature. For intranuc-
lear staining, the True Nuclear Transcription Factor Buffer Set (Biolegend; San Diego, CA)
was used according to manufacturer’s instructions. Briefly, cells were fixed in the TrueNuclear
fixation solution for 1 hour, then washed three times with the permeabilization buffer. Cells
were then stained with the transcription factors indicated in Table 1 at 4ºC for one hour, rinsed
three times with permeabilization buffer, then resuspended in FACS buffer. Flow cytometry
was performed on a BD LSR II (Becton Dickinson; Franklin Lakes, NJ), and the data were ana-
lyzed using FlowJo software for Macintosh (version 9.9.3 or version 10.1).
Ex vivo analysis of MAIT function with partially fixed bacteria
MAIT cell function was measured in vitro by adapting assays that were previously described
[52, 78]. Briefly, cryopreserved PBMC were rested for 6 hours in RPMI (Thermo Fisher
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Scientific) supplemented with 10% FBS, 4 mM L-glutamine, and 1X antibiotic/antimycotic
(Thermo Fisher Scientific Cat No. 15240062); this media will now be referred to as R10. For
the stimulus, E. coli and M. smegmatis stocks were fixed for approximately three minutes with
a 1% paraformaldehyde solution, washed three times with 1X PBS, and diluted to a working
concentration of 1x106 CFU/mL in R10. After the 6-hour resting period, approximately 10
CFU of the indicated fixed bacterium were added for each PBMC cell for 90 minutes to allow
for bacterial uptake into the cells. After this 90 minute period, cells were then incubated for 16
hours at 37ºC in the presence of 2 uM monensin (Biolegend; San Diego, CA), 5 μg/mL Brefel-
din A (Biolegend; San Diego, CA), and CD107a-APC (Table 1). Cells isolated from LNs were
incubated with bacteria for only 5 hours as the MAIT cell TCR is downregulated if the incuba-
tion period is too long. After incubation, cells were stained with the Mamu MR1-5OPRU tetra-
mer in R10+500 nM Dasatinib (Thermo Fisher Scientific) for 1 hour. Cells were washed once
with 1X PBS (Thermo Fisher Scientific) and live cells stained using the LIVE/DEAD NearIR
staining kit (Thermo Fisher Scientific) at a 1:4,000 dilution in 1X PBS. Cells were washed once
with PBS containing 10% FBS and then stained with CD3, CD4, and CD8 antibodies (Table 1).
Cells were fixed in 2% paraformaldehyde for 20 minutes, permeabilized in Medium B, and
stained with IFNγ and TNFα (Table 1). Flow cytometry was performed as indicated above.
Statistical analysis
Pearson’s correlation coefficients were calculated to determine the linear relationship between
the absolute MAIT cell counts and the Log10 CFU within each granuloma. For comparative
analysis of MAIT cell frequencies and phenotypes across cohorts, Mann-Whitney statistical
tests were performed where indicated to determine statistical significance between two treat-
ment groups, and Kruskall-Wallis tests with Dunn’s adjusted p values were used to define sta-
tistical significance between three groups. For characterization of longitudinal changes across
the same animals in a given cohort, repeated measures non-parametric ANOVA tests with
Tukey’s multiple test correction were performed to determine statistical significance. In situa-
tions where not all animals had longitudinally matched data (Figs 4B, 4C, 5D and Fig 8), Wil-
coxon Rank signed tests were performed for matched pairs. To characterize longitudinal
changes in the phenotypic markers present on MAIT cells during SIV infection, the data were
first normalized to the average frequency for each marker before SIV infection for each animal.
Then, the fold-change in expression of the indicated phenotypic marker relative to pre-infec-
tion measurement was calculated for every time point. Statistical significance was determined
using non-parametric ANOVA tests with Tukey’s multiple test correction. For granuloma/LN
immunological data, means were calculated per animal and graphed to ensure that granulomas
from individual animals were not biasing results. These graphs indicated that treatment effect
sizes (of means) were similar to those in graphs where all granulomas/LN samples were
pooled.
Supporting information
S1 Fig. Peripheral blood mononuclear cells (PBMC) and bronchoalveolar lavage (BAL)
were collected from the designated timepoints post-SIVmac239 infection and flow cyto-
metric analysis was performed as indicated in Figs 2 and 5. Then, CD8+MR1tet+ cells were
characterized for their expression of HLA-DR, TIGIT, ki67, CD39, and PD-1. Teal dots; CD8
+MR1tet+ cells from BAL, Crimson dots; CD8+MR1tet+ cells from PBMC.
(EPS)
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S2 Fig. Representative gating schematic for MAIT cell functional assays. Functional assays
were performed as described in Methods and Figs 7 and 8, and flow cytometric analysis was
performed. Top panels: representative gating schematic for CD8+MR1tet+ cells. Bottom 3
panels: CD107a (left), IFNγ, and TNFα were measured on CD8+MR1tet+ cells that were left
unstimulated, or stimulated with 10 CFU/cell of either fixed M.smegmatis (M.smeg) or fixed E.
coli. Total number of CD107a+, IFNγ+, and TNFα+ events within the CD8+MR1tet+ parent
gate (total events) are indicated in the boxes to the left of the flow plots.
(EPS)
S3 Fig. SIV and Mtb co-infection results in functional impairment of TNFα production in
conventional CD8+ T cells in the blood. A, Functional assays were performed as described in
Fig 8 using PBMC from pre-Mtb (dark grey) and 6 weeks post-Mtb (yellow) infection from
seven Mtb-infected MCM. Wilcoxon Rank sum statistical tests for matched pairs were per-
formed to compare the expression of the indicated cytokines or CD107a longitudinally from
conventional CD8+ T cells (CD8+MR1tet-) for a single stimulus. B, Functional assays were
performed as described in (A) using PBMC from pre-SIV (dark grey), 20 weeks post-SIV
(teal), and 6 weeks post-Mtb (yellow) infection from 8 SIV/Mtb coinfected MCM. Wilcoxon
Rank sum statistical tests for matched pairs were performed to compare the expression of the
indicated cytokines and CD107a longitudinally for a single stimulus. C, The functional assays
performed in (A) and (B) using PBMC from six weeks post-Mtb infection for SIV-naïve (blue
dots) and SIV+ (red dots) MCM were plotted on the same graphs to compare the expression
of CD107a (first panel), IFNγ (second panel), or TNFα (third panel) amongst the two cohorts.
Mann-Whitney tests were performed to determine statistical significance.
(EPS)
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